tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports

Taysha Gene Therapies (TSHA) Financial Statements

Compare
1,245 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently $1.24B. The company's EPS TTM is $-0.08; its P/E ratio is -16.13; Taysha Gene Therapies is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 9.77M$ 8.33M$ 15.45M$ 2.50M$ 0.00
Gross Profit$ 8.63M$ 8.33M$ 15.45M$ 15.00K$ 0.00
Operating Income$ -110.50M$ -91.46M$ -72.44M$ -126.03M$ -173.27M
EBITDA$ -109.35M$ -87.95M$ -105.20M$ -159.73M$ -172.60M
Net Income$ -109.00M$ -89.30M$ -111.57M$ -166.01M$ -174.52M
Balance Sheet
Cash & Short-Term Investments$ 319.77M$ 139.04M$ 143.94M$ 87.88M$ 149.10M
Total Assets$ 343.32M$ 160.36M$ 172.73M$ 126.28M$ 213.96M
Total Debt$ 18.17M$ 63.18M$ 61.11M$ 59.93M$ 63.09M
Net Debt$ -301.60M$ -75.86M$ -82.83M$ -27.95M$ -86.01M
Total Liabilities$ 96.38M$ 88.84M$ 97.79M$ 125.33M$ 118.57M
Stockholders' Equity$ 246.94M$ 71.53M$ 74.94M$ 949.00K$ 95.38M
Cash Flow
Free Cash Flow$ -93.83M$ -81.60M$ -80.39M$ -113.26M$ -138.60M
Operating Cash Flow$ -93.09M$ -81.22M$ -73.02M$ -88.39M$ -117.04M
Investing Cash Flow$ -604.00K$ -363.00K$ -7.35M$ -24.93M$ -21.55M
Financing Cash Flow$ 274.59M$ 76.68M$ 136.39M$ 52.10M$ 39.08M
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Income Statement >

Taysha Gene Therapies Debt to Assets

Balance Sheet >

Taysha Gene Therapies Cash Flow

Cash Flow >

Taysha Gene Therapies Forecast EPS vs Actual EPS

Earnings >